Partner News | Published: Monday, January 12, 2026
MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, announced a new industry partnership with Novo Nordisk, Inc., a global healthcare leader committed to transforming the management of chronic diseases, including obesity, diabetes and cardiovascular conditions.
With more than 40 years of U.S. operations, Novo Nordisk is driving innovation in cardiometabolic care through scientific leadership, investment in chronic disease research, and a focus on equitable access to care. The company’s efforts are aimed at addressing the high burden of unmet needs in the cardiovascular disease population, delivering tangible improvements in outcomes through research and sustainability initiatives.
“We are pleased to welcome Novo Nordisk to the MedAxiom community,” said Joe Sasson, PhD, MedAxiom’s executive vice president of Ventures and chief commercial officer. “Their expertise in chronic disease management and commitment to sustainable access bring meaningful insight to our members. We look forward to partnering on initiatives that improve care delivery and long-term outcomes for patients with cardiovascular disease.”
“We recognize the interconnectivity between diabetes, obesity, kidney disease and cardiovascular disease. Both our completed outcomes trials, and our robust cardiovascular pipeline, demonstrate our commitment to improving the lives of people facing serious chronic diseases. We are excited about our MedAxiom partnership, and look forward to continuing our work for patients fighting these diseases,” said Michelle Skinner, PharmD, Vice President, Medical Affairs at Novo Nordisk.
As part of its commitment, Novo Nordisk emphasizes a multifaceted approach to improving cardiometabolic health—advancing treatment options, addressing systemic barriers to care, and championing innovation across the care continuum.
About MedAxiom
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of hundreds of cardiovascular organization members, thousands of administrators, clinicians, and revenue cycle experts, and dozens of industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. For more information, visit medaxiom.com.
About Novo Nordisk
Novo Nordisk takes unordinary approaches to defeat serious chronic diseases, recognizing the need for innovative strategies to ensure long-term health. Headquartered in Plainsboro, NJ, Novo Nordisk operates across 12 U.S. locations and is dedicated to advancing care for chronic conditions such as obesity, diabetes, and cardiovascular disease, as well as rare and ultra-rare disorders. For more information, visit novonordiskmedical.com
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.